Overall, our findings demonstrated that, regardless of the time points along the timeline kinetics, CD4+CD38+ and CD8+CD69+ presented outstanding accuracy (AUC ≥ 0.9) in classifying COVID-19 patients vs. HCs. This evidence concerns the gene CD38 and COVID-19.